CDC Advisers Recommend Against J&J COVID-19 Shot Due to Blood Clotting Concerns

Advisers for the US Centers for Disease Control and Prevention have recommended that adults get COVID-19 vaccines manufactured by Moderna (MRNA) or Pfizer (PFE)/BioNTech (BNTX) over Johnson & Johnson's (JNJ) due to concerns that the J&J shot may be linked to a rare but serious blood clotting condition.

According to the Wall Street Journal, the CDC's advisory panel on immunization practices voted unanimously for the recommendation after a hearing on Thursday to review reports of serious blood clotting issues in a small number of J&J vaccine recipients.

There have been at least 54 reported cases of a rare condition called thrombosis with thrombocytopenia among people who received the J&J vaccine, including nine deaths. CDC officials said during the meeting that the rate was higher than previously estimated and affected a wider range of people, the WSJ reported.

Price: 172.75, Change: -0.26, Percent Change: -0.15